These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 17216817

  • 1. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
    Hartley MC, McKinley BP, Rogers EA, Kalbaugh CA, Messich HS, Blackhurst DW, Lokey JS, Trocha SD.
    Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 3. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG.
    Cancer; 2003 Mar 15; 97(6):1393-403. PubMed ID: 12627502
    [Abstract] [Full Text] [Related]

  • 4. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 5. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 7. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG, Yang Q, Moran MS, Tan AR, Reiss M.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1006-13. PubMed ID: 18262731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.
    Ai Zheng; 2005 Mar 15; 24(3):327-31. PubMed ID: 15757535
    [Abstract] [Full Text] [Related]

  • 10. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 15; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

  • 11. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.
    Kaplan HG, Malmgren JA, Atwood M.
    Breast J; 2009 Feb 15; 15(5):454-60. PubMed ID: 19671105
    [Abstract] [Full Text] [Related]

  • 12. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O, South-East Sweden Breast Cancer Study Group.
    Acta Oncol; 2009 Feb 15; 48(4):504-13. PubMed ID: 19235568
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 14. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
    Rhee J, Han SW, Oh DY, Kim JH, Im SA, Han W, Park IA, Noh DY, Bang YJ, Kim TY.
    BMC Cancer; 2008 Oct 23; 8():307. PubMed ID: 18947390
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA.
    J Am Coll Surg; 2005 Jun 23; 200(6):912-21. PubMed ID: 15922205
    [Abstract] [Full Text] [Related]

  • 16. [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].
    Yuan ZY, Wang SS, Gao Y, Su ZY, Luo WB, Guan ZZ.
    Ai Zheng; 2008 Jun 23; 27(6):561-5. PubMed ID: 18570725
    [Abstract] [Full Text] [Related]

  • 17. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.
    Cancer; 2003 Sep 01; 98(5):1055-60. PubMed ID: 12942575
    [Abstract] [Full Text] [Related]

  • 18. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT, Danish Breast Cancer Cooperative Group.
    J Natl Cancer Inst; 2011 Sep 21; 103(18):1363-72. PubMed ID: 21881042
    [Abstract] [Full Text] [Related]

  • 19. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
    Amornmarn R, Bui MM, Prempree TB, Masood S.
    Ann Clin Lab Sci; 2000 Jan 21; 30(1):33-40. PubMed ID: 10678581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.